International, multicenter phase II trial with humanized anti-GD2 monoclonal antibody naxitamab for treatment of refractory/relapsed high-risk neuroblastoma: Efficacy and safety data Meeting Abstract
| Authors: | Mora, J.; Chan, G.; Morgenstern, D.; Nysom, K.; Bear, M.; Dalby, L. W.; Lisby, S.; Kushner, B. |
| Abstract Title: | International, multicenter phase II trial with humanized anti-GD2 monoclonal antibody naxitamab for treatment of refractory/relapsed high-risk neuroblastoma: Efficacy and safety data |
| Meeting Title: | 52nd Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 67 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 14-17 |
| Meeting Location: | Virtual |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2020-12-01 |
| Start Page: | S294 |
| Language: | English |
| ACCESSION: | WOS:000581769201002 |
| PROVIDER: | wos |
| PUBMED: | 33049088 |
| DOI: | 10.1002/pbc.28742 |
| Notes: | Meeting Abstract: 0654 / #1022 -- Source: Wos |
